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In the adult brain, continual neurogenesis of olfactory
neurons is sustained by the existence of neural stem
cells (NSCs) in the subependymal niche. Elimination
of the cyclin-dependent kinase inhibitor 1A (p21)
leads to premature exhaustion of the subependymal
NSC pool, suggesting a relationship between cell
cycle control and long-term self-renewal, but the
molecularmechanisms underlying NSCmaintenance
byp21 remain unexplored.Herewe identify a function
of p21 in the direct regulation of the expression
of pluripotency factor Sox2, a key regulator of
the specification and maintenance of neural progen-
itors. We observe that p21 directly binds a Sox2
enhancer and negatively regulates Sox2 expression
in NSCs. Augmented levels of Sox2 in p21 null cells
induce replicative stress and a DNA damage re-
sponse that leads to cell growth arrest mediated
by increased levels of p19Arf and p53. Our results
show a regulation of NSC expansion driven by a
p21/Sox2/p53 axis.
INTRODUCTION
Stem cells persist in the adult brain in two discrete niches, the
subependymal zone (SEZ), which generates olfactory interneu-
rons and callosal oligodendrocytes, and the neurogenic subgra-
nular zone (SGZ) of the hippocampus. In the SEZ, in particular,
glial fibrillary acidic protein (GFAP) and Nestin-expressing multi-
potential astrocytes with rather long cell cycles (B cells) appear
to act as neural stem cells (NSCs). Activated, proliferative B cells
produce transit-amplifying progenitor cells, which primarily
differentiate into neurons (Zhao et al., 2008). These activated B
cells can be isolated and grown in culture as neurospheres
with mitogens epidermal growth factor (EGF) and/or basic fibro-88 Cell Stem Cell 12, 88–100, January 3, 2013 ª2013 Elsevier Inc.blast growth factor (bFGF); under these conditions, they exhibit
self-renewal and the potential to clonally differentiate into neu-
rons, astrocytes, and oligodendrocytes (Andreu-Agullo´ et al.,
2009). Lifelong neurogenesis and expansion of multipotent
cultures in vitro are a reflection of NSC self-renewal, an essential
property of stem cell populations that integrates cell proliferation
with themaintenance of an undifferentiated state. Self-renewal is
regulated by cell-extrinsic signals, produced within endogenous
stem cell niches, and intrinsic regulators. Among intrinsic modu-
lators, transcription factors that are important to sustain stem
cell developmental potential and modulators of the cell cycle
status appear especially relevant (Orford and Scadden, 2008).
SOX transcription factors are characterized by an SRY box,
a 79 amino acid high-mobility-group (HMG)-type DNA binding
domain (Wegner, 2011). Closely related factors Sox1, Sox2,
and Sox3 of the SoxB1 subfamily are expressed in most neural
stem/progenitor cells and play a role inmaintaining their undiffer-
entiated state, albeit with some functional redundancy (Graham
et al., 2003; Bylund et al., 2003; Bani-Yaghoub et al., 2006;
Miyagi et al., 2008; Wegner, 2011). Sox2, in particular, is
expressed at high levels in adult NSCs and is required for their
self-renewal. A reduction in Sox2 levels results in a loss of
GFAP-positive progenitor cells and deficient neurogenesis in
the murine hippocampus (Ellis et al., 2004; Ferri et al., 2004;
Favaro et al., 2009), and SOX2 hemizygosity in humans associ-
ates with neurological phenotypes and hippocampal malforma-
tion (Sisodiya et al., 2006). In addition, SOX2 expression is high
in gliomas and SOX2 silencing in glioblastoma tumor-initiating
cells reduces their proliferation (Gangemi et al., 2009). Despite
the relevant role of Sox2 in the regulation of normal and trans-
formed NSCs, very little is known about the control of Sox2
expression in adult NSCs.
Sox2 is present in long-lived adult stem cells and is essential
for the pluripotency of epiblast cells and embryonic stem cells
(ESCs) (Wegner, 2011; Arnold et al., 2011). In line with this,
Sox2 is one of the factors (together with Oct4/Klf4/c-Myc)
that mediate the reprogramming of terminally differentiated
somatic cells to a pluripotent state (Banito and Gil, 2010).
Cell Stem Cell
p21 Represses Sox2Reprogramming is highly improved by the ablation of different
senescence effectors, indicating that senescence acts as
a barrier for the completion of this process. In line with this,
ectopic expression of pluripotency factors in fibroblasts can
trigger senescence by upregulating the tumor suppressor p53
(also known as Trp53 in mice and TP53 in humans) and the cell
cycle regulator p21 (also known as Cdkn1a and Cip1) (Banito
and Gil, 2010; Blasco et al., 2011). Interestingly, cell cycling of
adult murine NSCs is tightly regulated by p21, seemingly in
a p53-independent manner (Kippin et al., 2005; Meletis et al.,
2006). NSCs that are deficient in p21 exhibit increased cell cycle
re-entry, leading to subsequent exhaustion of the NSC pool
(Kippin et al., 2005), though the mechanisms involved in p21-
dependent regulation of self-renewal are not understood.
Here we show that p21 directly binds to the Sox2 regulatory
region 2 (SRR2) enhancer downstream of the Sox2 gene and
inhibits the expression of this gene in adult SEZ-derived NSCs.
The loss of p21 results in increased levels of Sox2 leading to
replicative stress (RS) that ultimately results in an arrest in
stem cell growth that is dependent on the p53 and p19Arf tumor
suppressors. Our results indicate that the modulation of Sox2
levels by p21 could be a regulatory mechanism to control the
proliferation of NSC populations in the adult brain.
RESULTS
Sox2-Dependent Growth Arrest of p21-Deficient NSCs
Young p21-deficient mice exhibit increased numbers of long-
term 2-bromo-5-deoxyuridine (BrdU)-retaining cells in the SEZ
and yield more subependyma-derived neurospheres than wild-
type littermates (Kippin et al., 2005). In agreement with the role
of p21 as a cell cycle breaker in adult B NSCs, we observed in
the SEZ of 2-month-old p21-null mice a higher proportion of
GFAP/Nestin double positive (DP) cells (10.0% ± 2.6% versus
wild-type values of 3.5% ± 0.5%; n = 3, p < 0.05) and GFAP/
Nestin DP cells that were also positive for the cell proliferation
marker Ki67 (Figures 1A and 1B). We also observed increased
percentages of GFAP/Sox2 DP cells (44.3% ± 2.0% versus
wild-type values of 32.0% ± 2.7%; n = 3, p < 0.05) and of
GFAP/Nestin DP cells that were also positive for Sox2 (Figures
1B and 1C).
The levels of Sox2 in individual cells are variable among the
proliferating cells of the SEZ (Ferri et al., 2004; Ellis et al., 2004)
and, indeed, we could observe GFAP/Sox2 DP cells with
differing, high or low levels of Sox2 protein (Figure 1C). Intrigu-
ingly, the lack of p21 resulted in increased proportions of
GFAP-positive cells with high levels of Sox2 protein compared
to those of wild-type controls (Figures 1B-1E), suggesting
a potential regulation of Sox2 levels by p21. Moreover, p21-
null mice showed an increase in the percentages of Ki67-positive
cells within the GFAP/Sox2low population but a decrease in the
proportion of Ki67-positive cells among the GFAP/Sox2high pop-
ulation (Figures 1E and 1F). These data suggested that, whereas
more GFAP-positive B-type cells are cycling in the absence of
p21, a fraction of GFAP/Sox2high cells may be arresting.
Expression of p21 is indispensable for the long-term self-
renewal of adult NSCs and p21-null NSCs have a proliferative
advantage at young ages that leads to their accelerated con-
sumption during aging (Kippin et al., 2005). The exhaustionphenotype is readily manifested in vitro, when cells from
the SEZ are grown and passaged as clonal neurospheres under
mitogenic stimulation with EGF and FGF2. In fact, p21-null mice
yield higher numbers of neurospheres than wild-type controls,
but the cultures exhibit an eventual loss of neurosphere-forming
ability (Kippin et al., 2005). In agreement with these findings, we
observed that, in comparison with the wild-type litter mates,
cellular cultures derived from the SEZ of young p21 mutant
mice yielded higher numbers of primary neurospheres, which
produced increased numbers of passage (P) 1 neurospheres
that incorporated more BrdU (Figure 2A and Figures S1A and
S1B available online), but fewer secondary neurospheres after
P2 (95 ± 3 out of 500 cells plated in wild-type versus 69 ± 8 in
p21mutant cultures; n = 4, p < 0.01) when the cells were seeded
at 2.5 cells/ml to preserve the clonality of the assay (Ferro´n et al.,
2007). The results indicated defects in self-renewal that could be
observed at the level of a single neurosphere.
Because large neurospheres appear to be more self-renewing
(Kippin et al., 2005; Andreu-Agullo´ et al., 2009), we selected neu-
rospheres that were above 100 mm in diameter after 7 days
in vitro for analysis at each passage (Figures 2A and 2B). These
neurospheres always produced both large and small clones,
whereas further culture of the smaller neurospheres gave rise
only to spheres below the 100 mm cut-off (data not shown). Rela-
tive to those from wild-type controls, primary cultures from
p21-deficientmice yielded increased numbers of large P1 neuro-
spheres. However, these gave rise to neurospheres that dis-
played reduced BrdU incorporation without changes in survival
(Figures S1A–S1C), suggesting that the proliferation of p21-
deficient NSCs was impaired during passaging. With passaging,
the proportion of large neurospheres rapidly declined, reaching
exhaustion as early as P3, whereas the proportion of neuro-
spheres <100 mm increased (Figure 2C). This analysis indicated
a cell growth arrest of self-renewing NSCs in the absence of p21
and provided us with a system to examine molecular changes
underlying the exhaustion phenotype.
Using this system, we investigated Sox2 expression and
observed a specific upregulation of its mRNA (2.70 ± 0.12-fold
increase, n = 3; p < 0.01) in P2 large mutant neurospheres by
quantitative real-time polymerase chain reaction (qPCR) (Fig-
ure 2D). Confocal and quantitative fluorescence microscopy
also revealed a higher proportion of p21-null cells positive for
Sox2 and increased Sox2 protein levels per nucleus in p21-defi-
cient cultures (Figures 2E and S1D). These results indicated that
the upregulation of Sox2 in a p21-null background correlates
with impaired NSC expansion also in vitro.
We then performed rescue experiments by infecting single
cells obtained from P2-neurospheres with retroviruses carrying
p21 in the transfer vector pMSCV2.2-GFP-IRES-p21 (pMigR1-
p21). Re-expression of p21 rescued the proportion of large
P3-neurospheres to that of wild-type levels (Figures 2F
and 2G), indicating that the deficits are likely a direct result of
the loss of p21 in adult NSCs, in agreement with a previous report
that p21 loss has no apparent effects during fetal/early postnatal
development (Kippin et al., 2005). Restoration of p21 levels in
mutant cells and subsequent rescuing effects correlated with
reduced Sox2 protein levels (Figure 2H). To test whether aug-
mented levels of Sox2 were indeed responsible for the growth
arrest, we knocked down Sox2 expression in p21-deficientCell Stem Cell 12, 88–100, January 3, 2013 ª2013 Elsevier Inc. 89
Figure 1. Higher Levels of Sox2 in the SEZ of p21 Null Mice Negatively Correlate with B Cell Proliferation
(A) GFAP (green) and Nestin (red) (top panels) and Ki67 (red) (bottom panels) in wild-type (WT) or p21-null mice.
(B) Percentages of Ki67-positive and Sox2-positive cells within the GFAP/Nestin DP cell population.
(C) GFAP (green) and Nestin (red) (top panels) and Sox2 (orange) (bottom panels) in WT or p21-null mice.
(D) Percentage of Sox2high and Sox2low cells within the GFAP/Sox2 DP cell population.
(E) GFAP (green) and Sox2 (orange) (top panels) and Ki67 (red) (bottom panels) in WT or p21-null mice.
(F) Percentage of Ki67-positive cells within the GFAP/Sox2high and GFAP/Sox2low cells.
DAPI is used as nuclear counterstaining. The dashed white line indicates the lateral ventricle (v) limit. White arrows indicate triple positive cells. All images are
confocal 2 mm thick optical sections. Data are shown as mean values ± SEM (*p < 0.05; **p < 0.01). Scale bars: in (A), (C), and (E), 10 mm. See also Figure S1 and
Table S1.
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p21 Represses Sox2NSCs using short-hairpin RNAs (pRS-shRNA-Sox2; Banito et al.,
2009). Knockdown of Sox2 in wild-type cells leading to about
50% reduction of Sox2 mRNA levels slightly reduced the yield
of large P3-neurospheres. Remarkably, the reduction of Sox2
in p21 null NSCs rescued the numbers of large P3-neurospheres
to those of wild-type levels (Figures 2F, 2G, and 2I), an indication
that p21 maintains self-renewal by negatively regulating Sox2
expression.
The CKI p21 Regulates Sox2 Gene Expression
It has been shown that p21 can modulate transcription by direct
association with transcription factors/coactivators at specific
promoters in a cell-cycle-independent way (Dotto, 2000; Devgan
et al., 2005; Besson et al., 2008). Consistent with the possibility
that p21 might directly regulate the expression of Sox2,90 Cell Stem Cell 12, 88–100, January 3, 2013 ª2013 Elsevier Inc.a 2.5-fold increase in the expression of p21 over endogenous
levels led to a 70% reduction in Sox2 mRNA by qPCR (Fig-
ure S2A). Expression of Sox2 in ESCs and NSCs is under the
control of two enhancer regions, SRR1 and SRR2 (Figure 3A)
and reporter analysis in vivo indicates that the SRR2 element
(located 3 kbp downstream of the Sox2 gene) functions to upre-
gulate Sox2 expression in fetal NSCs and B cells of the adult SEZ
(Miyagi et al., 2004, 2006). Cytometry-based assays for the fluo-
rescent product of the Venus reporter gene driven by a herpes
simplex virus thymidine kinase basal promoter (positions 109
to 51) and the SRR2 region (positions 3641 to 4023) (Miyagi
et al., 2004) in wild-type NSCs indicated that conucleofec-
tion with a pcDNA3.1-p21 inhibited transcription from the
SRR2-TK-Venus reporter (45% ± 12% fluorescence intensity
relative to empty vector) while expression from the control
Figure 2. Growth Arrest of p21-Deficient NSCs Is Sox2 Dependent
(A) Schematic of the neurosphere (NSph) culture along the different passages (P).
(B) Phase contrast images of P2-NSphs from wild-type (WT) or p21-null mice (upper and lower panels, respectively) selected by size (left). Schematic depicting
the size-based selection of the cultures is shown at right.
(C) With passaging, p21-deficient NSC cultures undergo a premature growth arrest (left axis) that is associated with a decrease in the diameter of the NSphs
(right axis), relative to cultures from wild-type mice (100%, dashed line) (n = 5).
(D) Sox2 mRNA levels by qPCR, showing an increase of endogenous Sox2 expression in P2, but not P1, p21-deficient NSphs that correlates with reduced
clonogenicity of large NSphs.
(E) Sox2 (orange) in WT and p21-null NSCs. DAPI is used as nuclear counterstaining.
(F) Expression of p21 or knockdown of Sox2 rescues the growth arrest exhibited by p21-deficient NSCs (n = 3).
(G) Phase contrast images of p21-deficient neurospheres infected with retroviruses carrying an empty vector (EV), a p21 cDNA (p21), or a Sox2 shRNA.
(H) Immunoblot for Sox2 protein in p21-null cells transduced with empty vector (EV) or p21.
(I) Relative Sox2 expression by qPCR in p21 null cells transduced with EV or a specific shRNA.
Scale bars: in (E), 20 mm; in (B) and (G), 100 mm. Data are shown asmean ± SEM of the indicated number of the experiments (n) (*p < 0.05; **p < 0.01; ***p < 0.001).
See also Figure S1 and Table S1.
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p21 Represses Sox2TK reporter was unchanged (Figure 3B). In addition, we
observed a significant specific activation of the SRR2 reporter
in p21-null cells when compared to that of wild-type controls
(2.51 ± 0.05-fold increase in mean fluorescence intensity;
Figure 3C), indicating that p21 can regulate the SRR2 enhancer
activity.
To test the possibility of a direct interaction of p21 with the
SRR2 enhancer, we performed chromatin immunoprecipitation(ChIP) assays with anti-FLAG antibodies in chromatin isolated
from neurospheres that had been infected with retroviruses
bearing a GFP reporter, either empty (pMigR1) or containing a
p21-FLAG cDNA. The levels of p21 mRNA and protein achieved
by the retroviral infection of p21-deficient cells were similar to the
physiological levels observed in wild-type cells (Figures 3D
and 3E). Under these conditions, we observed specific binding
of FLAG-tagged p21 to the SRR2 enhancer that was validatedCell Stem Cell 12, 88–100, January 3, 2013 ª2013 Elsevier Inc. 91
Figure 3. p21 Inhibits Sox2 Gene Expression
(A) Regulatory regions in the murine Sox2 locus.
(B) Flow cytometric analysis of Venus expression in NSCs transfected with
the indicated reporters in the absence or presence of recombinant p21;
a representative experiment is shown (n = 2).
(C) Flow cytometric analysis of Venus expression in WT or p21-null NSCs;
a representative experiment is shown (n = 2).
(D) Immunoblot showing the levels of p21 in p21-null NSCs, or wild-type NSCs
left untreated (WT) or transduced with p21-expressing viruses (p21-FLAG).
Ponceau staining of the membrane is shown as a loading control.
(E) Levels of p21mRNA expression inWTNSCs infected with GFP (EV) or GFP-
p21-FLAG-expressing viruses (n = 3).
(F) NSCs infected with FLAG-tagged p21-expressing viruses were subjected
to ChIP assays with anti-FLAG or isotype control (IgG) antibodies. The graph
shows the quantitation of p21 binding to the indicated regions of theSox2 gene
by qPCR (n = 2).
Data are shown asmean ± SEM of the indicated number of the experiments (n)
(*p < 0.05). See also Figure S2 and Tables S1 and S2.
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92 Cell Stem Cell 12, 88–100, January 3, 2013 ª2013 Elsevier Inc.by qPCR of immunoprecipitated chromatin fragments. Primers
directed to a promoter region were used to confirm the binding
specificity (Figure 3F). Moreover, ChIP analysis in cells of
the c17.2 neural stem cell line with two different antibodies
evidenced specific binding of endogenous p21 to the SRR2
enhancer in contrast to the promoter region tested (Figure S2B).
These results indicate a direct role of p21 in the inhibition of the
SRR2 enhancer in NSCs.
Elevated Sox2 Levels Induce Senescence in
Neurosphere-Forming Cells
NSCs isolated from neonatal mice require Sox2 to grow and
self-renew (Favaro et al., 2009), but our results suggested that
upregulation of Sox2 in adult NSCs might impair self-renewal.
In pluripotent ESCs either a reduction or an increase in Sox2
levels can impair pluripotency and self-renewal (Kopp et al.,
2008), suggesting that Sox2 levels should be kept within strictly
regulated levels in stem cells. Moreover, overexpression of
reprogramming factors results in increased proportions of cells
displaying senescent features (Banito et al., 2009; Hong et al.,
2009; Kawamura et al., 2009; Mario´n et al., 2009; Li et al.,
2009; Banito and Gil, 2010). In agreement with this, we observed
that overexpression of Sox2 in mouse embryonic fibroblasts
(MEFs) caused a drastic reduction in cell proliferation, along
with a 2-fold increase in the proportion of senescence-associ-
ated (SA)-b-galactosidase-positive cells (Figures 4A and S3A).
To investigate the role of increased levels of Sox2 in the
regulation of adult NSCs features, wild-type cells were trans-
duced with retroviruses carrying pMY-GFP or pMY-GFP-IRES-
Sox2 and FACS-sorted cells were subjected to self-renewal
and clonal multipotency assays. Cultures overexpressing Sox2
(45% increase relative to controls, as determined by immuno-
blot) showed a reduction in the number (53% ± 11% decrease,
n = 5, p < 0.05) and size (57 ± 6 versus 96 ± 8 mm in diameter;
n = 5, p < 0.05) of secondary neurospheres when compared
with the GFP controls (Figures 4B and 4C). Moreover, when
these neurospheres were individually picked and allowed
to differentiate for 7 days and evaluated for the presence of
the three neural lineages (oligodendrocytes, astrocytes, and
neurons) by immunofluorescence, we found that overexpression
of Sox2 impaired NSC potentiality, reflected in a significant
increase in the proportion of unipotent, astrocyte-only clones
at the expense of tripotent clones (Figures 4B and 4D). Together,
these results indicated that elevated levels of Sox2 restrain
self-renewal of adult NSCs, reducing their neurosphere-forming
potential and multilineage differentiation. The increment in
Sox2 levels was not associated with increased apoptosis
(Figures S3B and S3C) but with a higher proportion of cells ex-
hibiting SA-b-galactosidase staining (Figure 4B). These results
indicated that reduced stem cell frequency and self-renewal
potential following overexpression of Sox2 were likely the result
of cell growth arrest/senescence in neurosphere-forming cells.
Increased Levels of DNA Damage in p21-Null Cells Are
Associated with Sox2 Overexpression
Senescence can be the result of replicative exhaustion or can be
elicited in response to stresses such as DNA damage (Collado
et al., 2007). In this regard, Sox2 overexpression in wild-type
NSCs resulted in significantly higher percentages of cells
Figure 4. Sox2 Overexpression in NSCs Induces Senescence
(A) MEFs were infected with empty vector (EV) or constructs encoding the indicated factors. Cells were selected for 7 days and used for crystal violet (upper
panels) or SA-b-galactosidase stainings (middle panels). Phase-contrast images of the cells at the end of the selection are shown (lower panels). Oncogenic Ras
V12 is used as a positive control.
(B) NSCs were infected with EV or Sox2. From the top: expression of Sox2 reduces the number and size of secondary neurospheres (phase-contrast; upper
panels), impairs multipotency (immunofluorescence with the indicated antibodies; middle panels), and induces senescence (SA-b-galactosidase; lower panels).
(C) Sox2 protein levels in the NSCs infected with EV or Sox2.
(D) Quantitation of the differentiation potential of the infected NSCs in (B) (n = 3).
Data are shown as mean ± SEM of the indicated number of the experiments (n) (*p < 0.05). Scale bars: in (B), upper panels 100 mm; middle panels 30 mm; lower
panel 50 mm. See also Figure S3 and Table S1.
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p21 Represses Sox2immunopositive for the form of histone H2AX phosphorylated
in serine 139 (gH2AX), a widespread marker of DNA damage
and RS (Figures 5A–5C). Since gH2AX can be phosphorylated
at stalled replication forks even in the absence of DNA breakage,
we also analyzed the presence of nuclear foci of 53BP1,
which specifically marks sites of chromosome breaks. Forced
expression of Sox2 led to a 2-fold and 5-fold increase in the
percentage of gH2AX-positive or 53BP1 foci-containing cells,
respectively, relative to those of the controls (Figures 5C
and S4). Oncogene-induced DNA breaks that promote senes-
cence are thought to be initiated by RS, which, if persistent,
can lead to chromosomal breakage. Indeed, Sox2-transduced
cultures contained more cells exhibiting single-stranded (ss)
DNA-binding replication protein A (RPA32) foci typically associ-
ated with stalled DNA replication forks and RS (Figures 5B
and 5C).
Similarly to Sox2-overexpressing cells, we observed higher
proportions of cells with RPA32- and 53BP1-positive foci and
gH2AX in p21 null cultures than in wild-type controls (Figures
5D–5F), an indication of augmented RS and DNA damage.
Reintroduction of a full-length p21 cDNA restored the increased
percentages of 53BP1-positive cells to wild-type levels (Fig-
ure 5F). Since our results indicated that lack of p21 results in
genomic instability, we next investigated whether this correlated
with the deregulation of Sox2 expression. Indeed, 70% ± 15% of
the Sox2-positive p21-null cells were also positive for gH2AX,
suggesting that increased Sox2 levels could be behind the
instability found in p21-deficient NSCs.
Analyses in vivo showed a general increase in the proportion of
GFAP-positive cells that were also positive for gH2AX (59.5% ±
3.9%versuswild-type values of 44.5%± 2.9%; n = 6, p < 0.05) or
RPA foci (56.1% ± 6.2% versus wild-type values of 30.4% ±3.3%; n = 3, p < 0.05) and an increase in the percentage of
gH2AX-positive cells within the GFAP/Sox2high population in
p21 null mice (Figures 5G and 5H). It has been reported that
H2AX can also be phosphorylated by kinases of the PIKK family
in response to GABA signals that are naturally produced in the
subependymal niche, suggesting that activation of a H2AX
signaling pathway may represent one mechanism restricting
NSC proliferation under physiological conditions (Fernando
et al., 2011). However, 80.8% ± 3.8% of the gH2AX/GFAP DP
cells in the SEZ of p21-deficient mice presented additional
evidences of DNA breakage such as 53BP1 foci, in contrast to
a wild-type value of 37.3% ± 4.2% (n = 3, p < 0.001). To provide
formal genetic proof that the origin of the DNA damage found on
p21-null mice was linked to RS, we focused on the Chk1 kinase,
which coordinates the RS response, and took advantage of
a recently generated mouse strain carrying an extra allele of
Chk1 (Chk1Tg), which is selectively protected from RS (Toledo
et al., 2011; Lo´pez-Contreras et al., 2012). Importantly, the intro-
duction of theChk1Tg on the p21 null background diminished the
percentage of GFAP/Sox2-positive cells showing gH2AX phos-
phorylation (Figures 5G and 5H). All together, these results
support the idea that Sox2 overexpression in p21-deficient
NSCs leads to RS and subsequent DNA breakage.
DNA Damage Checkpoint Activation in p21-Null Is Sox2
Dependent
Senescence is controlled by the tumor suppressor p53 and by
p16Ink4a (p16) and p19Arf (encoded by alternative reading frames
of the Ink4a/Arf locus, also known as Cdkn2a) (Collado et al.,
2007; Banito and Gil, 2010). Oncogene-induced stress results
in increased production of p19Arf, which, in turn, raises p53 levels
by inhibiting MDM2, the E3-ubiquitin ligase mainly responsibleCell Stem Cell 12, 88–100, January 3, 2013 ª2013 Elsevier Inc. 93
Figure 5. Genomic Instability in p21-Deficient NSCs Is Associated with Sox2 Deregulation
(A) Examples of Sox2-transduced NSCs showing increased immunostaining for gH2AX (green) and 53BP1 (red) relative to empty vector (EV) cells.
(B) Examples of Sox2-transduced NSCs showing increased immunostaining for gH2AX (green) and RPA32 (red) relative to EV cells.
(C) Quantitation of 53BP1, gH2AX, and RPA stainings in NSCs overexpressing Sox2 relative to EV-transduced cells (dashed line) (n = 3).
(D) Examples of p21-null cells showing increased immunostaining for gH2AX (green) and 53BP1 (red) relative to WT cells.
(E) Examples of p21-null cells showing increased immunostaining for gH2AX (green) and RPA32 (red) relative to WT cells.
(legend continued on next page)
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Figure 6. DNA Damage Checkpoint Activa-
tion in p21-Null and Sox2-Overexpressing
Cells
(A) Crystal violet staining of murine p53-null MEFs
transduced with empty vector (EV) or constructs
encoding the indicated factors. Sox2 over-
expression does not induce cellular senescence
in the absence of p53. Oncogenic Ras V12 is used
as a positive control.
(B) Sox2 overexpression in NSCs induces an
increase in p53 protein levels.
(C) Retroviral expression of Sox2/GFP decreases
the number of secondary neurospheres inWT, but
not in p53-null, cultures. Treatment of Sox2/GFP-
transduced cells with the ATM inhibitor KU55933
restored neurosphere formation to the levels
found in GFP (EV)-transduced cells (n = 3).
(D) Assessment in WT or p21-null NSCs of p16
and p19Arf mRNA levels by qRT-PCR (n = 3).
(E) Levels of immunostaining for p16, p19Arf, and
p53 in the nuclei of WT and p21-null cells, as
measured by quantitative fluorescence micros-
copy (n = 3).
(F) p21-deficient neurospheres were transduced
with control (), p53, or p16/p19Arf shRNAs. The
graph shows the rescue of the growth arrest
observed in p21-deficient NSCs by knocking
down p16/19 or p53. The inset shows the
knockdown efficiency of the indicated shRNA
constructs by qPCR analysis. Data are shown as
mean ± SEM of the indicated number of the
experiments (n) (*p < 0.05). See also Figure S5 and
Tables S1 and S2.
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p21 Represses Sox2for its degradation (Collado et al., 2007). In this regard, forced
expression of pluripotency factors induces the accumulation
of p53, p16, and/or p19Arf proteins in MEFs and p19Arf acts
as the main barrier to reprogramming in murine cells (Li et al.,
2009; Banito and Gil, 2010). In fact, we observed that overex-
pression of Sox2 in wild-type, but not p53-deficient, MEFs led
to a cell growth arrest associated with an increase in the levels
of the products of the Cdkn2a gene (Figures 6A and S5A and
S5B). We also observed an accumulation of the p53 protein
in NSCs in response to increased levels of Sox2, and, more
importantly, Sox2 overexpression did not affect the self-
renewal of p53 null NSCs (Figures 6B and 6C). Together, these(F) Bar graph showing the quantitation of 53BP1, gH2AX, andRPA32 stainings in p21-null cells relative toWT-E
re-expressing p21 (p21 null+p21FL) (n = 3).
(G) SEZ sections from WT mice, p21-null mice, or p21-null;Chk1Tg stained with the indicated antibodies. Triple
(H) Bar graph showing the proportions of GFAP/Sox2 DP cells that are also gH2AX positive in the SEZ of p21-n
p21-null;Chk1Tg mice (n = 3 animals per genotype).
All in vivo images are confocal 2 mm thick optical sections. Data are shown as mean ± SEM of the indicated nu
Scale bars: in (A), (B), (D), and (E), 10 mm; in (G), 10 mm. See also Figure S4 and Table S1.
Cell Stem Cell 12, 88–10findings demonstrated that expression
of Sox2 above physiological levels
induces cell growth arrest in a p53-
dependent manner.
It has been reported that oncogene-
dependent RS can induce a DSB-initi-
ated DNA damage response (DDR) within
a single cell cycle (Bartkova et al., 2006;Di Micco et al., 2006). In agreement with this, oncogene-induced
senescence could be bypassed by depletion of the DSB-respon-
sive kinase ATM (Shiloh, 2003). Since DSB markers such as
53BP1 foci are elevated on p21-deficient NSCs, to determine
whether the DDR was involved in the growth arrest induced by
Sox2 overexpression,we tested the effect of KU55933, a specific
pharmacological inhibitor of ATM, in the ability of GFP and GFP-
Sox2 overexpressing NSCs to form neurospheres. Despite
a limited toxicity of the drug, Sox2-overexpressing cultures
treated with 1 mM KU55933 yielded neurosphere numbers
similar to those of GFP controls (Figure 6C). Furthermore, perma-
nent inhibition of the ATM kinase by continual treatment with theV (dashed line) cells and of 53BP1 in p21-null NSCs
positive cells are indicated by white arrowheads.
ull andWTmice and in the SEZ of p21-null;WT and
mber of the experiments (n) (*p < 0.05; **p < 0.01).
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p21 Represses Sox2drug rescued the yield of P3-large mutant neurospheres to wild-
type values (wild-type: 33.1 ± 5.2; p21 null: 6.7 ± 1.2; p21-null
treated with KU55933: 29.0 ± 0.1; n = 2–7).
Expression analysis by qPCR indicated that, while there was
no change in the levels of p16 between genotypes, the levels
of p19Arf mRNA went up by 2-fold in p21-null NSCs (Figure 6D).
In addition, quantitative microscopy revealed a higher amount of
p19Arf and p53 proteins per nucleus in p21-null NSCs compared
to those of wild-type NSCs (Figure 6E). Retroviral delivery of p16/
p19Arf or p53 shRNAs to p21-null P2 cells did not modify the
proportions of cells positive for gH2AX (38.3% ± 2.3% empty
vector; 30.0% ± 4.0% shRNA-p16/19Arf; 32.6% ± 3.2%
shRNA-p53; n = 3) but restored the yield of large P3-neuro-
spheres to wild-type levels (Figure 6F). Therefore, overexpres-
sion of Sox2 in p21-deficient NSCs triggers a p53-dependent
cell growth arrest that could be initiated by the DDR and/or the
induction of p19Arf expression.
We next sought to determine whether the increase in DNA
damage markers was causally linked to Sox2 overexpres-
sion. Remarkably, the proportion of gH2AX-positive cells was
decreased to wild-type values upon reduction of Sox2 levels
in vitro by shRNA delivery (Figure 7A), suggesting that increased
Sox2 activates the DDR in a similar fashion to the aberrant
expression of oncogenes.
In order to analyze whether increased levels of Sox2 were also
at the basis of the phenotypes observed in the p21-null mice
in vivo, we crossed p21 knockout mice with Sox2 heterozygous
mice and analyzed the offspring for DNA damage and RS
markers in the SEZ. We observed that mice with reduced levels
of Sox2 (p21 null/Sox2-het; Figure S7) showed reduced levels of
DNA damage markers and fewer GFAP-positive cells or GFAP/
Nestin DP cells that were also positive for gH2AX or 53BP1
foci just by visual examination (Figure 7B). The signs of RS in
p21-null mice, determined by the presence of RPA32 foci in
GFAP/Nestin cells, also appeared alleviated in a Sox2 heterozy-
gous background (Figure 7C). Interestingly, DCX-positive neuro-
blasts derived fromGFAP-positive B cells also displayed signs of
RS in p21-null mice, which were reduced to wild-type levels in
p21-null/Sox2-het mice (Figure 7D). The quantitations showed
that reduction of Sox2 levels in a p21-null background indeed
decreased the percentages of GFAP/gH2AX DP cells with
53BP1 foci, and the percentages of GFAP/Nestin DP cells and
DCX-positive neuroblasts that were also positive for RPA32
foci, to wild-type levels (Figures 7E and 7F). In conclusion, the
results presented here indicate that p21 preserves integrity of
the NSC genome by finely modulating the levels of Sox2.
DISCUSSION
The Cip/Kip p21 is a well-known cell cycle regulator and acts as
a molecular break inducing a permanent cell cycle arrest (senes-
cence) in response to DNA damage and p53 activation in most
primary cells (Besson et al., 2008). Interestingly, p21 appears
to mediate a distinct cellular response in stem cell populations.
In NSCs and hematopoietic stem cells (HSCs), cell cycle restric-
tion by p21 appears to be critical for self-renewal, as p21-defi-
cient NSCs and HSCs proliferate more actively but become
consumed over time (Kippin et al., 2005; Orford and Scadden,
2008). Still, the molecular mechanisms by which p21 regulates96 Cell Stem Cell 12, 88–100, January 3, 2013 ª2013 Elsevier Inc.stem cell pools remain largely unknown. Our data support
a model in which p21 can regulate NSC self-renewal, at least
in part by repressing Sox2 gene expression.
We show that p21 associates to the Sox2 enhancer SRR2 and
represses Sox2 gene expression. It has been reported that p21
does not bind directly to regulatory elements but can act as
a repressor through binding to transcription factors, such as
E2F1, c-Myc, or STAT3 (Dotto, 2000; Devgan et al., 2005).
Recent data has indicated that p27, another member of the
Cip/Kip subfamily of CKIs, also acts as a transcriptional
repressor through binding to p130-E2F4 complexes; bound
p27 is needed for the subsequent recruitment of mSin3A,
a core protein of a corepressor HDAC1/HDAC2 histone deacety-
lase complex (Pippa et al., 2012). Although p21 can interact with
E2F-containing complexes, expression of p130 and E2F4 is very
low in our proliferating neurospheres and, moreover, p21 does
not appear to be required for the binding of mSin3A to the
SRR2 enhancer (data not shown), suggesting that p21 actions
onSox2 transcription in NSCs likely depend on a different molec-
ular mechanism. The specific activity of SRR2 in fetal NSCs is
specified mainly by the Sox2 protein itself with the contribution
of POU-domain proteins such as Brn-1, Brn-2 and Brn-4 or
Oct6, in a way similar to the regulation of this enhancer in embry-
onic cells by Oct3/4-Sox2 complexes (Miyagi et al., 2004).
Therefore, further work will be necessary to address whether
interactions of p21 with any of these transcriptional regulators
underlie its role in the repression of Sox2 in NSCs.
The work presented here also indicates that (1) in response to
mitogenic stimuli, p21-deficient NSCs undergo cell growth arrest
and exhibit signs of DNA damage that are reminiscent of RS and
can, therefore, be alleviated by expression of an extra copy of
Chk1; (2) Sox2 expression in NSCs is repressed by p21 and
this correlates with a direct binding of p21 to the Sox2 enhancer;
and (3) Sox2 depletion limits the damage that is observed in p21-
deficient NSCs, both in vitro and in vivo. The results suggest
a model whereby the repression of Sox2 by p21 is essential for
maintaining a proper regulation of cell-cycle transitions in
NSCs. In the absence of p21, Sox2 overexpression would allow
a promiscuous entry in S-phase and therefore RS, which would
ultimately limit NSC clonogenic potential. The mechanism by
which NSCs undergo p53-mediated senescence in the absence
of p21 is still unclear. It has been reported that p53 can induce
cell growth arrest in the absence of p21 by increasing the expres-
sion of the genes encoding for Gadd45 and 14-3-3 proteins
sigma (Taylor and Stark, 2001). However, we could not detect
an increase in the expression of these genes in p21 null NSCs
(data not shown), suggesting that p53 may act in combination
with yet other pathways to induce a growth arrest.
Normal stem cells are known to accumulate DNA damage
during successive replication rounds that, in the end, compro-
mises stem cell function (Rossi et al., 2007; Nijnik et al., 2007).
Moreover, several lines of evidence suggest that stem cells
demand an especially tight control of replication to prevent repli-
cative damage. First, ESCs and iPSCs accumulate copy number
variations (CNVs) upon serial culture (Na¨rva¨ et al., 2010; Laurent
et al., 2011), a type of genomic aberrations that are hallmarks of
RS. Second, previous evidence exists to suggest that enhanced
expression of stemness factors, including Sox2, in somatic cells
generates RS and the activation of a p53- and p21-dependent
Figure 7. Genomic Instability in p21-Null Cells Can Be Restored by Reduction of Sox2 Levels
(A) Lack of p21 leads to an increase in gH2AX staining, which is rescued by Sox2 knockdown in neurosphere cells (n = 3).
(B) GFAP (red), gH2AX (red), and 53BP1 (green) in WT, p21-null, or p21-null/Sox2-het mice.
(C) GFAP (red), Nestin (green), and RPA32 (red) in WT, p21-null, or p21-null/Sox2-het mice. White arrows indicate triple positive cells in (B) and (C).
(D) DCX (green) and RPA (red) in WT, p21-null, or p21-null/Sox2-het mice. White arrows indicate DP cells.
(E) Graph showing the proportions of gH2AX and GFAP DP cells that are also positive for 53BP1 in WT, p21-null, or p21-null/Sox2-het mice (n = 3).
(F) Graph showing the proportions of Nestin and GFAP DP cells (left bars) and of DCX-positive neuroblasts (right bars) that are also RPA32 positive in WT,
p21-null, or p21-null/Sox2-het mice (n = 3). DAPI (blue) is used for counterstaining.1 All images are confocal 2 mm thick optical sections. Data are shown as
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Finally, several genomic analyses identified CNV events that
were generated de novo during reprogramming, arguing that re-
programming factors can be inducers of RS (Blasco et al., 2011).
Hence, stemness is a state that is particularly prone to RS, and
stemness factors have been shown to actively induce RS in
embryonic cells. We here show that deregulated expression of
Sox2 is also a potent inducer of RS in NSCs. Given that onco-
genes are known to induce RS (Bartkova et al., 2006; Di Micco
et al., 2006), Sox2-induced RS might easily be related to its
oncogenic role (Gangemi et al., 2009) and to its high expression
in brain tumors (Phi et al., 2008). In agreement with this notion,
oncogene-induced RS is exacerbated in the context of a deregu-
lated G1/S checkpoint, such as in the absence of p53 (Toledo
et al., 2011). Hence, the findings reported here could be ex-
plained by a proproliferative role of Sox2 in NSCs, which gener-
ates RS by facilitating promiscuous S-phase entry, and which is
limited by p21. Importantly, gH2AX is also seen in vivo in p21-
deficient brains, and can be alleviated by the depletion of Sox2
or by an additional copy of the Chk1 allele. We propose that
these observations constitute an in vivo case of RS and senes-
cence induced by a pluripotency factor.
One important difference of our findings from oncogene-
induced DNA damage is that the RS observed in NSCs is p21
dependent in a p53-independent manner (Besson et al., 2008).
We believe that this could be explained by a limited role of p53
in the regulation of the G1/S transition on NSCs. In support of
this view, and in contrast to what is observed in p21-deficient
NSCs, lack of p53 in NSCs does not result in their exhaustion
(Meletis et al., 2006). Moreover, whereas p53 deficiency is
synthetic lethal with the deletion or hypomorphism of ATR at the
organism level (Murga et al., 2009; Ruzankina et al., 2009), this
synthetic lethal effect is not seen on neural progenitors of the fetal
brain (Lee et al., 2012). Hence, p53 seems to play a limited role in
suppressing RS on NSCs. It is noteworthy that deletion of p21 in
leukemic stem cells has also been shown to exacerbate DNA
damage independently of p53, which, similarly to our observation
on NSCs, also ends up limiting the self-renewal of these cancer
cells (Viale et al., 2009). In this context, p21 would paradoxically
be working as an oncogene, since it extends the proliferative life-
span of cancer stem cells by limiting replication-born genomic
damage. Whether this role on leukemic stem cells is also related
to the abnormal expression of proproliferative stemness factors
including Sox2 remains unknown, but in favor of this view, SOX2
amplifications and altered expression have been found in human
cancers that are not only of a brain origin (Bass et al., 2009; Maier
et al., 2011). New oncogenic roles for cell cycle inhibitors are now
being proposed (Besson et al., 2008) and, for example, PDGF-
induced gliomagenesis is reduced in mice lacking p21 (Liu et al.,
2007). To what extent p21 might be particularly important in
safeguarding the genome of cancer stem cells in SOX2 overex-
pressing tumors is an interesting venue for future research.EXPERIMENTAL PROCEDURES
Animals
Mice of the p21 (Brugarolas et al., 1995), p53 (Donehower et al., 1992),
Chk1 (Lo´pez-Contreras et al., 2012), and Sox2 (Avilion et al., 2003)
mutant strains were crossed and maintained at the University of98 Cell Stem Cell 12, 88–100, January 3, 2013 ª2013 Elsevier Inc.Valencia animal core facility in accordance with Spanish regulations (RD1201/
2005).
Cell Culture, Transduction, and Cytometry
Neurospheres were cultured and analyzed as described (Kippin et al., 2005;
Ferro´n et al., 2007; Andreu-Agullo´ et al., 2009). Large neurospheres were
selected using a 100 mm cell strainer (BD Falcon). Vectors containing Sox2
shRNAs have been described (Banito et al., 2009). shRNAs for p53 and p16/
p19Arf were encoded in MLP vectors (Thermofisher). Methods used for retro-
virus production, isolation of MEFs, and MEF infection have been described
(Banito et al., 2009; Barradas et al., 2009). NSCs were seeded at clonal density
and infected overnight by incubation with diluted (1:4) viral supernatants
produced in 293T cells (see also Supplemental Information available online).
Transduced GFP-positive cells were isolated using a MoFlo cell sorter
(Dako). For the reporter assays, 1.6 3 104 live cells were collected and only
the Venus-positive population (about 22%) was analyzed 48 hr postnucleofec-
tion in a BD FACSCanto II (BD Biosciences) flow cytometer using FlowJo
V7.6.1 (Tree Star Inc.) software.
Immunocytochemistry
Cells were fixed with 2% paraformaldehyde for 20 min, incubated in
blocking buffer (10% normal goat serum and 0.2% Triton X-100 in 0.1M
phosphate buffer saline) for 30 min, and incubated overnight at 4C with
the indicated primary antibodies (see Table S1, available online). After
several washes with PBS, immunoreactivity was detected with Cy3- or
Cy2-conjugated secondary antibodies (1:500; Jackson InmunoResearch
Labs.) or with biotinylated antibodies (1:300, Vector Laboratories) followed
by Cy2-labeled streptavidin (1:200; Jackson InmunoResearch Labs). Cells
were counterstained with 40,60,-diamidino-2-phenylindole (DAPI) and
mounted with Fluorsave (Calbiochem). For gH2AX, RPA, and 53BP1
stainings, cells were fixed with 1% formaldehyde for 10 min followed by
methanol at 20C for 2 min. Brains were obtained and sectioned as
described (Andreu-Agullo´ et al., 2009). Sections were incubated with the
indicated antibodies (Table S1) and immunoreactivity was detected as
above. Immunofluorescence quantitative microscopy was done in an InCell
Analyzer 1000 using InCell Investigator software (GE), and at least 1,000 cells
were counted in each acquisition (see Supplemental Experimental
Procedures for details). Confocal images were taken in an Olympus
Fluoview FV10i scanning confocal microscope and analyzed with the
FV10-ASW 2.1 or the public domain Java image processing ImageJ
software. For quantitation of Sox2 expression in vivo, immunofluorescent
signals in each cell were measured as mean pixel (px) density as follows:
above background, 5 px; Sox2high R 50 px; Sox2low = 4–50 px; and
Sox2negative % 4 px.
RNA Isolation and qRT-PCR Analysis
Total RNA was extracted using TRIzol and cDNA synthesized using
SuperScript III reverse transcriptase kit (Invitrogen). cDNA products were
amplified using an Applied Biosystems StepOne plus Fast Real-Time PCR
system. Taqman probes for mouse Sox2, p21, p53, Gadd45, Sigma14-3-3,
and Gapdh were purchased from Applied Biosystems. Primer sequences
used for qPCR assessment of p16, p19Arf, and control b2 microglobulin
expression are listed in Table S2.
ChIP Analysis and Immunoblotting
ChIP procedure on neurospheres has been previously described in detail
(Andreu-Agullo´ et al., 2009). Immunoprecipitated DNA was purified with the
Wizard SV Gel and PCRClean Up System and analyzed by qPCR. Primer pairs
gave a single product as confirmed by dissociation curve analysis. The primers
used to amplify the UTR and SRR2 regions are listed in Table S2. Immunoblot-
ting was carried out using standard procedures. Antibodies used in these
procedures are listed in Table S1.
Statistical Methods
Results are presented as mean ± SEM of a number (n) of independent exper-
iments. Statistical significance was determined by two-way Student’s t tests
using SPSS software.
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